Analysis of the Impact of the Covid-19 Pandemic on the Epidemiological Profile of Acinetobacter SPP Infections in Patients Hospitalized in Intensive Care Units of a Tertiary Hospital in Recife, Pe
Retrospective analysis reveals increased mortality from Acinetobacter spp infections during COVID-19 in ICU patients, indicating urgent public health concerns.
Key Points
The study aims to analyze the effects of the COVID-19 pandemic on Acinetobacter spp infections in ICU patients.
Retrospective descriptive analysis of medical records from adult ICU patients (2018–2022) with Acinetobacter spp infections.
Comparison of data between pre-pandemic and pandemic periods, focusing on mortality and infection characteristics.
Assessment of antibiotic susceptibility and resistance patterns among isolated strains.
Out of 732 patients, the pre-pandemic mortality rate was 39.1%, compared to 54.2% during the pandemic.
32.3% of patients evaluated during the pandemic also had COVID-19.
Colistin and polymyxin B showed the highest susceptibility, while meropenem and imipenem had the greatest resistance.